Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
NCT03739827
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small percentage of these tumors are familial. Researchers want to study these changes in biological samples from people with rare tumors in order to learn more about how these tumors develop. The information obtained from this study may lead to improved screening, preventive guidelines, and treatments. Objective: To better understand rare cancers and hereditary cancer syndromes.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Malignant Solid Tumors
- Other Neoplasms Solid Tumors
- Pediatric Solid Tumor
- Refractory Solid Tumors
- Solid Tumor
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 4 weeks and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Cancer Institute (NCI)
- Last updated on ClinicalTrials.gov
- October 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Oregon · 1
- Oregon Health and Science University · Portland, OR
Texas · 1
- Texas Children's Hospital · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.